Schedule 13G ownership disclosure
ENDONOVO THERAPEUTICS, INC.
Security class unavailable · CUSIP: 29272H201
Event date: 2015-10-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-15-059553
- Form type
- SC 13G
- Filer
- ENDONOVO THERAPEUTICS, INC.
- CIK
- CIK 1528172
- Filed
- Oct 15, 2015
- Reporting period
- Oct 15, 2015
- Description
- Schedule 13G beneficial ownership